Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > FDA

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Nov 28, 2022 3:58pm

93 Views

Post# 35134846

RE:RE:RE:RE:RE:RE:RE:RE:FDA

Hey MDJ, The OTC (pink sheets) exchange is for companies that don't meet the requirements of the major exchanges. Generally speaking, institutional invstors won't go anywhere near them. I figured with all of the chatter about the anticipation of Biden legalizing cannabis federally and FDA approvals, LABS's investment exposure in the US will be extremely limited without a NASDAQ listing. Yes, other mj companies have done it, like Aurora Cannabis, which did a 12:1 reverse split. Investors got killed with that one (current share price is $1.79 and it has to reach $106 for investors prior to the split to break even). Who knows, they may just stick with the TSXV and OTC, but I doubt it.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide